Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal-bolus vs Sliding-scale Insulin in Hospitalized T2DM
NCT01594060Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Jun 2012
- Primary completion
- Oct 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of insulin glargine, insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Emek Medical Center. Started Jun 2012; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01594060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594060.